Pelago Bioscience AB

Pelago Bioscience AB

Scheeles väg 1 171 65 Solna Sweden

CETSA Technology

CETSA Technology

CETSA® by Pelago Bioscience is a well-proven, best-in-class technology used to assess cellular protein-ligand binding. CETSA® can be applied throughout all steps of the drug discovery value chain. Because neither the ligand nor the protein is modified, CETSA® provides reliable measurements of target engagement in authentic cellular environments and under actual physiological conditions. In this way, biologically relevant values can be obtained from any type of cellular matrix – i.e. cell lines, animal tissue or patient samples – to help you explore, discover and confirm drug candidates faster.

Intellectual Property

Pelago Bioscience was founded to provide and develop the patented Cellular Thermal Shift Assay (CETSA®) in 2013. The CETSA® method is patented in most regions worldwide

Product Enquiry

SSL Secure Connection